Abstract

HomeJournal of the American Heart AssociationVol. 12, No. 5Correction to: Antiatherosclerotic Effects of CSL112 Mediated by Enhanced Cholesterol Efflux Capacity Open AccessCorrectionPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citations ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toOpen AccessCorrectionPDF/EPUBCorrection to: Antiatherosclerotic Effects of CSL112 Mediated by Enhanced Cholesterol Efflux Capacity Originally published21 Feb 2023https://doi.org/10.1161/JAHA.121.027554Journal of the American Heart Association. 2023;12:e027554This article corrects the followingAntiatherosclerotic Effects of CSL112 Mediated by Enhanced Cholesterol Efflux CapacityOther version(s) of this articleYou are viewing the most recent version of this article. Previous versions: February 21, 2023: Ahead of Print In the article by Bronwyn A. Kingwell et al, “Antiatherosclerotic Effects of CSL112 Mediated by Enhanced Cholesterol Efflux Capacity,” which published online April 12, 2022 (J Am Heart Assoc. 2022;11:e024754. DOI: 10.1161/JAHA.121.024754) and was included in the April 19, 2022 issue of the journal, a correction was needed.On page 4 of the article, in the third line of the section “Plaque Stabilization,” the sentence reading “CSL111 is a predecessor compound formulated with higher apoA‐I/phosphatidylcholine molar ratio than CSL112.” was incorrect. It has now been corrected to read “CSL111 is a predecessor compound formulated with higher phosphatidylcholine/apoA‐I molar ratio than CSL112.”The authors regret the error.The online version of the article has been updated and is available here:https://www.ahajournals.org/doi/10.1161/JAHA.121.024754 Previous Back to top Next FiguresReferencesRelatedDetailsRelated articlesAntiatherosclerotic Effects of CSL112 Mediated by Enhanced Cholesterol Efflux CapacityBronwyn A. Kingwell, et al. Journal of the American Heart Association. 2022;11 March 7, 2023Vol 12, Issue 5Article InformationMetrics Copyright © 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley BlackwellThis is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.https://doi.org/10.1161/JAHA.121.027554PMID: 36802969 Originally publishedFebruary 21, 2023 PDF download

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call